AptaBio Therapeutics Inc Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - AptaBio Therapeutics Inc

Watchlist Manager

Watchlist

Price: 6 600 KRW 3.94% Market Closed

Market Cap: ₩185.4B

A	AptaBio Therapeutics Inc KOSDAQ:293780	KR
K	Kimberly-Clark Corp XMUN:KMY	US
	Newmark Group Inc NASDAQ:NMRK	US
B	BHP Group Ltd NYSE:BHP	AU
I	InterDigital Inc F:IDI	US

Profitability Summary

AptaBio Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

48%

Sustainable 3Y Average Gross Margin

21%

Negative Operating Margin

-394%

Negative 3Y Average Operating Margin

-2 971%

Operating Margin is Increasing

-21 392% > -394%

Negative Net Margin

-313%

Negative 3Y Average Net Margin

-2 982%

Net Margin is Increasing

-23 288% > -313%

Negative Free Cash Flow Margin

-366%

Negative 3Y Average Free Cash Flow Margin

-944%

Free Cash Flow Margin is Increasing

-1 920% > -366%

Negative ROE

-31%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-43%

ROIC is Increasing

-47% > -45%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.